The genome of the human parvovirus B19 contains a transcriptional promoter (BP06) at map position 6, upstream from the nonstructural protein genes. By cotransfecting HeLa cells with this promoter cloned before the chloramphenicol acetyltransferase (CAT) gene together with a plasmid containing almost the whole B19 genome, we showed that BPO6 is transactivated by a B19 gene product. The transactivating viral protein was identified as the nonstructural protein NS-1. NS-1 synthesized in a wheat germ extract specifically stimulates transcription from BPO6 in vitro. NS-1 of the minute virus of mice (MVM) activates the analogous MVM promoter, MP04. NS-1, therefore, has a positive feedback effect on the activity of its own promoter. Moreover, NS-1 of MVM activates the human BPO6. We have identified, in the genome of B19, a second transcriptional promoter activity at map position 44, before the capsid protein genes. This promoter, BP44, was identified by cloning fragments of B19 DNA upstream of the CAT gene, transfecting the DNA into HeLa cells, and measuring CAT expression. The strength of the BP44 promoter is similar to that of the capsid gene promoter, MP39, of MVM. In (nonpermissive) HeLa cells, the BP44 promoter is not activated by NS-1. Thus, the BPO6 promoter apparently does not determine the tissue specificity of B19 virus but BP44 could do so.
Autonomous parvoviruses show a strong tropism towards dividing cells because of their requirement for a cellular factor expressed during the S phase of the cell cycle. Several of these viruses are extremely tissue specific, able to grow only in cells at a particular stage of differentiation (for reviews, see references 5, 39, and 44).
B19 virus is the first human autonomous parvovirus described (8) . It is the causal agent of erythema infectiosum, or fifth disease (1) . B19 virus also provokes aplastic crises in anemics (31, 36) , a consequence of the fact that the virus grows lytically in erythroid progenitor cells at a precisely defined stage of differentiation (24) . Until now, no cell line permissive for B19 virus growth has been found. The virus is able to replicate to some extent in cultures of freshly isolated human bone marrow cells, although permissive cells represent only a minor portion of these cultures (27) . Cotmore and Tattersall (11) have cloned most of the genome of B19 virus from a viremic serum, which allowed the determination of the viral DNA sequence (38) . The genomic organization of B19 virus resembles that of other autonomous parvoviruses in terms of number and location of open reading frames (ORFs): there are two large nonoverlapping ORFs, together occupying a large part of the genome. In addition, two small ORFs are found in the middle and near the right end of the viral DNA (10, 38) . We and others (6, 17, 26) showed previously that a transcriptional promoter (BP06) is present at the left end of the genome of B19 virus; this promoter is active in vitro as well as in vivo.
In comparison with B19 virus, the autonomous parvoviruses, minute virus of mice (MVM) and the closely related H-1 virus, have been well studied (for a review, see reference 43) . Two strains of MVM have been isolated: MVMi, infecting lymphocytes, and MVMp, infecting fibroblasts (2, 42) . The DNA sequences of H-1 (30) and of both strains of MVM (3, 4, 37) have been determined. The genomes of these * Corresponding author. viruses contain two overlapping transcription units (29) : one promoter (MP04) located at 4 map units, directs transcription of the genes of the two nonstructural proteins, whose coding region is situated in the left part of the genome; the promoter of the second unit (MP39) is located at 39 map units and is responsible for the transcription of the capsid protein genes situated on the right part of the genome (12, 20, 34) . The MP04 promoter is active earlier in the lytic cycle than is MP39 (8) . Rhode (33) has reported that the nonstructural protein, NS-1, of H-1 virus is involved in the transactivation of the capsid gene promoter and has identified a cis-acting element present in this promoter which responds to NS-1 (35) . We have previously shown, by cotransfection experiments, that in MVMi the nonstructural protein NS-1 (hereafter called MNS-1) stimulates in trans the MP39 promoter (17) .
In the work reported here, we investigated the effect of the nonstructural proteins NS-1 of B19 virus and of MVMi on the activity of their own promoters, BPO6 and MP04. Unexpectedly, we found a positive feedback effect. Until now, there has been no report of a late promoter upstream of the capsid protein genes of B19 virus (26) . This is surprising, since other parvoviruses contain such a late promoter (5) . By cloning fragments of B19 viral DNA into plasmid vectors containing the chloramphenicol acetyltransferase (CAT) gene, we found evidence for a promoter at map position 44 just before the capsid protein genes of B19 virus.
MATERIALS AND METHODS
T4 DNA polymerase, T4 DNA ligase, restriction enzymes, SP6 RNA polymerase, RNase-free DNase, and RNasin were purchased from Boehringer GmbH, Mannheim, Federal Republic of Germany, and were used according to Maniatis et al. (22) or the protocol of the supplier.
Plasmid construction. The construction of pMP39-CAT, pEMBL/i0099 (2) , pEMBL/i0052, pMNS-1m, pMNS-2m, pMNS-2mcapm (17) , pEMBL/B19, and pBP06-CAT (16) Construction of pMP04-CAT. The TaqI restriction fragment containing the MP04 promoter was isolated from the clone pEMBL/i0099; one TaqI site is in the polylinker, and the other one is at position 228, so that the fragment was about 240 base pairs long. This fragment was blunt ended with T4 DNA polymerase, ligated to HindlIl linkers, and inserted into the HindlIl cloning site of pSV0-CAT. Both orientations were obtained as determined by digestion with Hinfl (site at position 225).
Construction of pSP6-BNS-l. We inserted the B19 virus restriction fragments RsaI-HindIII (nucleotides [nt] 333 to 595) and HindIII-PstI (nt 595 to 3145) into a SmaI-and PstI-cut pSP65 vector in a single trimolecular ligation reaction (see Fig. 3) ; the RsaI and SmaI blunt ends were ligated together, allowing the viral HindIII-PstI fragment to insert in its expected position. Recombinant plasmids were checked by digestion with restriction enzymes and by transcription with SP6 RNA polymerase of the plasmid linearized with different restriction enzymes.
Construction of pBP44-CAT. We isolated the SmaITthlllI fragment (nt 2073 to 2277) from pEMBL/B19, made it blunt with T4 DNA polymerase, ligated it to 8-mer HindIll linkers, and inserted it into the HindIII cloning site of the plasmid pSV0-CAT. Both orientations were obtained, as determined by digestion of the recombinant plasmid with Avall (position 2075). The other B19-CAT plasmids ( Fig. 1) were constructed by similar methods.
Construction of pBl9-capm. This clone was constructed by digestion of pEMBL/B19 with PstI, followed by isolation of the larger fragment (containing the vector [14] by the DEAE-dextran method (17) . At 48 h posttransfection, we The structure of these plasmids and how they were made has prepared cell extracts and measured the CAT activity, using 14C-already been described (17) . When the plasmid cotransfected labeled chloramphenicol as a substrate (17 phosphate, 0.1 ,ug of poly(dIC), and 25 ,il of HeLa nuclear pMNS-lm, on the other hand, had no effect on the expresextract; portions from in vitro translation reactions were sion of CAT from pMP04-CAT (Fig. 2, lane 7) . Thus, NS-1 added as described in the text. The reaction was carried out seems to be necessary for the transactivation of MP04. The at 30°C for 1 h, and the nucleic acids were then purified by clone pMNS-2m which expresses NS-1 (and the domain of digestion with pronase (0.1 ,ug/ml) for 20 min at 37°C in the NS-2 which is shared with NS-1) transactivates MP04 as presence of 1% sodium dodecyl sulfate extraction with efficiently as does the whole MVMi genome. We noted that phenol, addition of 10 ,g of carrier tRNA, and ethanol the CAT activity was somewhat lower when transactivation precipitation. They were redissolved in water and denatured was by pEMBL/i0052 (Fig. 2 Fig. 2 . The promoter-containing plasmids tested were pMP04-CAT (0.5 ,ug) (lanes 1 through 5), pMP39-CAT (1 ,ug) (lanes 6 through 8), and pBP06-CAT (0.5 ,ug) (lanes 9 through 13). The 3) . By analogy to MVM, the protein responsible for the transactivation of the BPO6 promoter might be expected to be BNS-1. To test this hypothesis and to check in a more direct way the effect of BNS-1 on the activity of the BPO6 promoter, we synthesized BNS-1 in vitro and tested the ability of this protein to modulate transcription from the BPO6 promoter in vitro.
In vitro synthesis of BNS-1. We obtained BNS-1 in vitro by translating in a cell extract the RNA synthesized by the SP6 RNA polymerase from the plasmid pSP6-BNS-1 (Fig. 4A) . Transcripts produced by SP6 RNA polymerase with this plasmid used as a template are shown in Fig. 4B . We linearized the plasmid template with PstI and used the runoff transcripts synthesized (containing the whole BNS-1 coding region) as a template for cell-free translation in a wheat germ extract (Fig. 4C ). The protein produced had the expected apparent molecular mass as deduced from the DNA sequence (38) , about 72 kilodaltons (Fig. 4C, lane 4) . The strong band at 68 kilodaltons, corresponding presumably to premature termination of translation, has also been detected in in vitro translation experiments using mRNA extracted from B19-infected bone marrow cells (17, 28) . The bands of lower molecular mass were probably also products of premature translation termination, since they were absent in reaction mixtures containing no exogenous mRNA (data not shown). The full-length protein and the lower-molecularmass bands were immunoprecipitable with an anti-BNS-1 antiserum raised against a fusion protein containing the carboxy-terminal part of BNS-1 (Fig. 4C, lanes 2 and 3) but not with a preimmune serum (Fig. 4C, lane 1 parvovirus activate transcription from the other? To answer this question, we first performed cotransfections of HeLa cells by using pBP06-CAT and pMNS-2mcapm; this latter plasmid is a modified MVMi clone able to express only MNS-1 (17). In Fig. 3 , lanes 9 through 13 show that MNS-1 is able to activate expression from the BPO6 promoter with the same efficiency as BNS-1. We also tested the symmetrical combination and cotransfected pMP04-CAT together with pB19capm, a clone containing the left part of B19 virus genome, from the left end to the PstI site at position 3145 (Fig. 1) . The result (Fig. 3, lanes 1 through 5) shows that B19 virus nonstructural protein activates expression from the MP04 promoter but to a lesser extent than MNS-1 does. Such a cross-transactivation was not observed with the capsid gene promoter MP39: this promoter was activated by pMNS-2mcapm but not by pB19capm (Fig. 3, lanes 6 through  8) .
Promoter (Fig. 1) , transfected them into HeLa cells, and measured the CAT activity in the transfected cells. The cells transfected with plasmids containing both TATA elements did not produce any CAT activity above the background level (data not shown); on the other hand, the plasmid pBP44-CAT, containing the viral fragment SmaI-TthlllI (nt 2071 through 2247), induced the expression of CAT (Fig. 6, lane 6) . The same fragment inserted in the opposite orientation relative to the CAT gene did not lead to the production of CAT (Fig. 6, lane 1) . By transfecting various amounts of DNA, the strength of the promoter activity in pBP44-CAT was compared with that in pMP39-CAT (a plasmid in which the CAT gene is under the control of the MP39 promoter of MVMi [17] ). The two promoters had very similar activities (Fig. 6, compare lanes  2 through 4 with lanes 6 through 8, respectively) .
The basal activity of the BP44 promoter in pBP44-CAT was not increased when the HeLa cells were cotransfected with pEMBL/B19 containing almost all the B19 genome (Fig.  6, lane 9) . The BP44 promoter in plasmid pBP44HT-CAT which contains a longer stretch of upstream sequence (Fig.  1) was likewise not transactivated (data not shown). The MP39 promoter of MVM, on the other hand, was transactivated by cotransfection with the equivalent MVM clone, pEMBL/i0099 (Fig. 6, lane 5; 17) . MP39 was not activated by NS-1 of B19 virus nor was BP44 activated by MNS-1 (Fig. 3 (1 ,ug) was also cotransfected in lane 9. CAT assays were as described in the legend for Fig. 2. plasmid expressing NS-1. Regulation of CAT expression could occur at various levels (43) . Secondly, the amount of mRNA transcribed from the MP04 promoter is lower in transfected cells containing a mutated NS-1 protein than in cells containing the wild-type NS-1 (17) . Thirdly, NS-1 of B19 virus synthesized in vitro activates transcription from BPO6 in vitro. The same result has been obtained with MVM NS-1 and the promoter MP04 (unpublished results).
Rhode and Richard (35) characterized a cis-acting element in the P38 promoter of H-1 virus which responds to NS-1 (H-1 is a virus closely related to MVM). They reported that the minimal sequence required for transactivation is a sequence of 13 base pairs, named tar, located between positions -138 and -126 relative to the start site of the capsid gene mRNA. The MP39 promoter of MVMi has an almost identical sequence between positions 1868 and 1880 (that is, from -139 to -127 relative to the cap site of the capsid mRNA; see Fig. 7 ). This is not surprising, since the viruses are related. A DNA sequence related to the central core portion of the tar element, TGGTTGGT, is present unexpectedly often throughout the MVM genome (7) . The (35) were not given, although cell lines different from those in the present work were used. On the other hand, the NS protein of B19 virus was reported not to suppress transcription from the BPO6 promoter (25) . We suggest that, as these early promoters are relatively strong, the amount of CAT gene-containing test plasmid added to the cells may have been such that the basal level of CAT expression was already high, so the subsequent transactivation that we observed was not measurable.
Why should NS-1 activate its own promoter, while other viral regulatory proteins (for example, the T antigen of simian virus 40 (32) or ICP4 of herpes simplex virus [30] ), repress theirs? The reason might be that NS-1, unlike these other viral regulatory proteins, is also a component of the virus particle: NS-1 of MVM is attached to the 5' end of viral DNA (13) . NS-1 would be needed, towards the end of the lytic cycle, for incorporation into viral progeny.
Transcriptional A feature shared by the early and late promoters of MVM and H-1 virus is the presence of the tar sequence, about 100 base pairs upstream from the TATA boxes (discussed earlier). This is also true of the two promoters which we have detected in B19 virus (Fig. 7A) : an identical sequence of 7 nt lies upstream of the TATA box of the BPO6 and BP44 promoters; this sequence occurs nowhere else in the B19 virus genome. Moreover, the sequence is homologous to the tar elements of MVM; in B19 virus, it is slightly closer to the RNA start site than the tar sequence is to the RNA start site in MVM (Fig. 7A and B) . The roles that these elements in B19 virus promoters may play in the regulation of viral transcription remain, as with MVM, to be demonstrated experimentally. Nevertheless, our results show that there are many similarities between the BP44 promoter and the MP39 promoter: at the structural level, they are located a similar distance upstream of the capsid protein ORF (and within the coding region of the NS-1 gene). They contain a sequence element which is also present in the promoter controlling the transcription of the nonstructural protein genes; this element resembles the tar which has been shown in H-1 virus to play a role in the regulation of transcription by NS-1. At the functional level, both promoters have a similar activity in transfected HeLa cells. Thus, we believe that the internal promoter activity in B19 virus could be responsible for transcription of capsid protein genes, as it is in other parvoviruses.
A promoter located near the middle of the genome of B19 virus was also reported by Deiss et al. (V. Deiss, J. Tratschlin, and G. Siegl, 2nd Parvovirus Workshop Abstracts, Oxford, U.K., p. 21, 1987) , who used a similar approach to that described in this report. However, Osawa et al. (26) proposed a transcriptional map for B19 virus in which all of the viral transcripts are initiated at the BPO6 promoter. Their data were obtained by successive hybridization of filter-bound RNA from cultured bone marrow cells infected with B19 virus with several labeled viral DNA fragments. They found evidence for nine viral transcripts generated from the BPO6 promoter; some transcripts had a structure unable to code for any polypeptide. Osawa et al. (26) also looked for a late promoter within the B19 virus genome by linking B19 virus DNA fragments to the CAT gene. They did not find the promoter we detected (at map position 44) because they looked only as far as map position 38.
Our results show that the BP(6, but not the BP44 promoter, is transactivated by BNS-1 in nonpermissive cells. As pointed out elsewhere (27) , the permissive cells represent only a minor fraction of the cells present in the bone marrow cell cultures. Thus, it is possible that the viral transcripts originating from BPO6 only, as detected by Osawa et al. (26) , are produced mainly during the abortive infection of the nonpermissive cells present in large excess over the permissive cells in the bone marrow culture. The uninduced activities of BP44 and MP39, although easily detectable in CAT assays, are low. We have not been able, with an RNase protection assay, to detect RNA generated from the BP44 promoter in HeLa cells transfected with pEMBL/B19. This is not surprising, since, with the same assay, we also did not detect the mRNAs for MVM capsid proteins in the absence of transactivation of MP39 (17; data not shown).
Control of transcription in B19 virus. We have shown that transactivation by NS-1 of the promoter controlling transcription of the nonstructural protein genes occurs in B19 virus as well as in MVM. The fact that in HeLa cells the promoters BP06 and MP04 respond to BNS-1 and MNS-1 indicates that these proteins are functionally closely related and that transactivation of these promoters is not, apparently, a cell-type-specific process. The main difference we have observed in the transcriptional organization of these viruses is that in HeLa cells the capsid protein gene promoter of MVM (MP39) is strongly transactivated by MNS-1 (17) , whereas the analogous promoter activity (BP44) of B19 is not stimulated by BNS-1. Perhaps there is no transactivation of the BP44 promoter by NS-1 in transfected HeLa cells because these cells lack an additional factor needed for efficient use of this promoter. Transactivation may occur in other types of cells able to support a productive infection. The tissue specificity of B19 virus may be thus related to regulation of viral transcription.
